Tumor immune microenvironment modulation-based drug delivery strategies for cancer therapy
The past years witnessed the promising clinical feedback of anti-cancer immunotherapies, which have become one of the hot topics, although limited with poor delivery kinetics, narrow patient response profiles, or systemic side effects. To the best of our knowledge, the development of cancer is highly associated with the immune system, especially the tumor immune microenvironment (TIME). Based on the comprehensive understanding of the complexity and diversity of TIME, drug delivery strategies focused on the modulation of TIME could be of great significance for directing and improving cancer immunotherapy. This review will highlight the TIME modulation in cancer immunotherapy and summarize the versatile TIME modulation-based cancer immunetherapeutic strategies, medicative principles and accessory biotechniques for further clinical transformation. Remarkably, the recent advances of cancer immunotherapeutic drug delivery systems and future prospects of the TIME modulation-based drug delivery systems for much more controlled and precise cancer immunotherapy will be emphatically discussed.
- This article is part of the themed collection: Recent Review Articles